Timolol
- Level
- Commodity
- Parent
- 51263100
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51263136This classification denotes a beta-adrenergic blocking agent with the molecular formula 2C13H24N4O3S.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 817W3C6175, chemically known as 2-propanol, 1-((1,1-dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)-oxy)-, (+-)- but generally known as timolol, which bears US NIH Compound Identifier 5478. European Medicines Agency schedules Timolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11069MIG. World Health Organization schedules timolol in its Anatomical Therapeutic Chemical (ATC) Classification. TIMOLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule timolol under HS 29349990 and SITC 51579. As of Q4 2014, TIMOLOL remains the US FDA Preferred Term for this commodity. Timolol bears US NLM identifiers UMLS ID C0040233 and NCI Concept Code C47757. SMILES: CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O.
Same parent
Under 51263100 · 75Activities that produce or sell this
KBLI · 8Inherited from family 51260000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.